Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Leoni

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Plos One|November 7, 2015
Nanomolar Caffeic Acid Decreases Glucose Uptake and the Effects of High Glucose in Endothelial CellsLucia Natarelli, Giulia Ranaldi, Guido Leoni, et al.
Mediators of Inflammation|January 24, 2014
Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patientsAlessandra Pecorelli, Guido Leoni, Franco Cervellati, et al.
Scientific Reports|April 27, 2017
Structural and biochemical insights of CypA and AIF interactionBiancamaria Farina, Gianluigi Di Sorbo, Angela Chambery, et al.
Journal for Immunotherapy of Cancer|November 30, 2025
Neoadjuvant personalized viral vaccine prevents tumor relapse in checkpoint-resistant murine melanoma modelLaura Seclì, Linda Nocchi, Guido Leoni, et al.
Frontiers in Immunology|May 14, 2023
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancerAnna Morena D'Alise, Linda Nocchi, Irene Garzia, et al.
Molecular Therapy. Oncology|April 10, 2024
Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumorsFulvia Troise, Guido Leoni, Emanuele Sasso, et al.
Cancers|November 20, 2020
Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of <i>Herpes Simplex</i> Oncolytic VirusGuendalina Froechlich, Carmen Caiazza, Chiara Gentile, et al.
Veterinary and Comparative Oncology|February 27, 2019
Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanomaDiana Giannuzzi, Laura Marconato, Ramy Elgendy, et al.
Journal for Immunotherapy of Cancer|April 28, 2023
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activityLaura Seclì, Luigia Infante, Linda Nocchi, et al.
Cancer Immunology Research|February 8, 2024
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer VaccineIrene Garzia, Linda Nocchi, Lidia Avalle, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Plos One|November 7, 2015
Nanomolar Caffeic Acid Decreases Glucose Uptake and the Effects of High Glucose in Endothelial CellsLucia Natarelli, Giulia Ranaldi, Guido Leoni, et al.
Mediators of Inflammation|January 24, 2014
Genes related to mitochondrial functions, protein degradation, and chromatin folding are differentially expressed in lymphomonocytes of Rett syndrome patientsAlessandra Pecorelli, Guido Leoni, Franco Cervellati, et al.
Scientific Reports|April 27, 2017
Structural and biochemical insights of CypA and AIF interactionBiancamaria Farina, Gianluigi Di Sorbo, Angela Chambery, et al.
Journal for Immunotherapy of Cancer|November 30, 2025
Neoadjuvant personalized viral vaccine prevents tumor relapse in checkpoint-resistant murine melanoma modelLaura Seclì, Linda Nocchi, Guido Leoni, et al.
Frontiers in Immunology|May 14, 2023
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancerAnna Morena D'Alise, Linda Nocchi, Irene Garzia, et al.
Molecular Therapy. Oncology|April 10, 2024
Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumorsFulvia Troise, Guido Leoni, Emanuele Sasso, et al.
Cancers|November 20, 2020
Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of <i>Herpes Simplex</i> Oncolytic VirusGuendalina Froechlich, Carmen Caiazza, Chiara Gentile, et al.
Veterinary and Comparative Oncology|February 27, 2019
Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanomaDiana Giannuzzi, Laura Marconato, Ramy Elgendy, et al.
Journal for Immunotherapy of Cancer|April 28, 2023
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activityLaura Seclì, Luigia Infante, Linda Nocchi, et al.
Cancer Immunology Research|February 8, 2024
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer VaccineIrene Garzia, Linda Nocchi, Lidia Avalle, et al.
Pageof 5